Gilead and PAHO agree on lenacapavir HIV prevention access in Americas

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. RTX
6. COF
7. SMCI
8. TSLA
9. BRZE
10. GOOGL

Go back to Gilead and PAHO agree on lenacapavir HIV prevention access in Americas

Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean

September 15, 2026 11:10 AM EDT

Agreement Establishes a Regional Pathway Through PAHOs Regional Revolving Funds to Support Country-Led Adoption of Long-Acting HIV Prevention

Partnership Advances Gileads Global Access Strategy, Helping Turn Scientific Innovation into Public Health Impact

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new agreement with the... More